Study Stopped
Money issues
Non-invasive Assessment of Colonic Motility
non-CoMoti
Electro-Entero-Graphy (EEnG) for Non-invasive Diagnosis of Motility Disorders of the Bowel
1 other identifier
observational
34
1 country
1
Brief Summary
The current diagnostic process of colonic motility disorders often takes a long time and involves multiple invasive, painful and/or unnecessary diagnostic procedures. To improve this diagnostic process, the potential of Electro-Entero-Graphy (EEnG) is investigated. During the EEnG procedure, several surface electrodes are positioned (under ultrasound guidance) on the abdomen so that electrical activity originating in the colon can be measured. Measurements will be performed after a period of fasting (when the colon is 'silent') and just after a meal (when the colon is moving) in both participants suffering from colonic motility disorders and healthy controls. It is hypothesized that these measurements are an indication of colonic motility and can be used as a diagnostic tool for colonic motility disorders. It is also hypothesized that this EEnG procedure is not more burdensome than the Gold Standard procedures for diagnosing colonic motility disorders. This will be assessed using questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2020
CompletedFirst Posted
Study publicly available on registry
November 10, 2020
CompletedStudy Start
First participant enrolled
February 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 12, 2022
CompletedMay 19, 2022
April 1, 2022
1.2 years
October 29, 2020
May 12, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Power Percent Difference
Relative power change when comparing pre-prandial EEnG measurements to post-prandial measurements. Power will be calculated as the mean amplitude (mV\^2/Hz) in a bandwidth of 2 cycles per minute around the dominant frequency related to colonic movements (between 2-10 cycles per minute).
During EEnG procedure
Secondary Outcomes (2)
EEnG questionnaire score
Directly after EEnG procedure, which is a one time procedure the subjects in this study will undergo
Gold Standard questionnaire score
Directly after EEnG procedure, which is a one time procedure the subjects in this study will undergo, or directly after the gold standard procedure, which some subjects will undergo in the near future at time of inclusion
Study Arms (4)
Children with motility disorder
Healthy children
Adults with motility disorder
Healthy adults
Interventions
Fasting, after which pre- and postprandial EEnG measurements are performed.
Filling out questionnaire about EEnG procedure.
Filling out questionnaire about Gold Standard diagnostic used to diagnose colonic motility disorder.
Eligibility Criteria
All subjects fulfilling the in- and exclusion criteria will be included. Participants with (suspected) motility disorder will be recruited mainly in the Radboudumc and with the help from the Hirschsprung's patient association.
You may qualify if:
- All participants:
- Age ≤ 11 years for babies and children
- Age ≥ 18 years for adults.
- Patients
- For babies/children:
- suffering from surgically untreated HSCR as determined by a rectal biopsy, or
- suspected of HSCR, for which a rectal biopsy is planned
- For adults: Suffering from a (suspected,) surgically untreated functional colonic motility disorder (such as slow-transit constipation, idiopathic/therapy resistant constipation of the colon), as diagnosed previously or will be diagnosed in the near future using the gold standard method.
You may not qualify if:
- All participants:
- For adults: BMI \> 27 kg/m2
- For babies/children: weight for length \> 2.5 standard deviations of WHO Child Growth Standard
- Pregnancy
- Diabetes
- Any food intolerance
- Presence of an intestinal stoma
- Use of continuous tube feeding
- Healthy controls:
- The presence of any known gastro-intestinal conditions
- Use of laxatives in the past two years
- Participants with (suspected) motility disorder:
- (Part of) colon removed
- Inflammatory bowel disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Radboudumc
Nijmegen, Gelderland, 6525 GA, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
S.M.B.I. Botden, MD
Radboud University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 29, 2020
First Posted
November 10, 2020
Study Start
February 25, 2021
Primary Completion
May 12, 2022
Study Completion
May 12, 2022
Last Updated
May 19, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- After publication of the results.
- Access Criteria
- Upon reasonable request via e-mail.
IPD will be available to other researchers on reasonable request.